Products for Research Use Only
RegisterLogin

Pexidartinib hydrochloride

CAT: 0013-GTR19185796-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19185796-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Pexidartinib hydrochloride (PLX-3397 HCl) is an orally bioavailable, ATP-competitive inhibitor targeting CSF1R (IC50=20 nM) and c-Kit (IC50=10 nM) . It induces apoptosis and is widely used in preclinical research to investigate tumor-associated macrophages and oncology in both in vitro and in vivo models.
CAS Number
2040295-03-0
Product Name Alternative
PLX3397 hydrochloride, PLX-3397 hydrochloride
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.88% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble) ; DMSO:48 mg/mL (105.66 mM)
Smiles
Cl.FC (F) (F) C1=NC=C (C=C1) CNC2=NC=C (C=C2) CC3=CNC=4N=CC (Cl) =CC43
Molecular Formula
C20H16Cl2F3N5
Molecular Weight
454.28
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Pexidartinib Hydrochloride

Pexidartinib Hydrochloride is the hydrochloride salt form of pexidartinib, a small-molecule receptor tyrosine kinase (RTK) inhibitor of proto-oncogene receptor tyrosine kinase (KIT), colony-stimulating factor-1 receptor (CSF1R) and FMS-like tyrosine kinase 3 (FLT3), with antineoplastic activity. Upon oral administration, pexidartinib targets, binds to and inhibits phosphorylation of KIT, CSF1R and FLT3 harboring an internal tandem duplication (ITD) mutation. This results in the inhibition of tumor cell proliferation. FLT3, CSF1R and FLT3 are overexpressed or mutated in many cancer cell types and play major roles in tumor cell proliferation and metastasis.

CAS Number2040295-03-0
PubChem CID73053710
IUPAC Name5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]pyridin-2-amine;hydrochloride
Molecular FormulaC20H16Cl2F3N5
Molecular Weight454.3
Topological Polar Surface Area66.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Heavy Atom Count30
Formal Charge0
Complexity537
SMILES
C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F.Cl
InChI
InChI=1S/C20H15ClF3N5.ClH/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24;/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29);1H
InChIKey
CJLUYLRKLUYCEK-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Pexidartinib Hydrochloride
CAS: 2040295-03-0
CID: 73053710
Formula: C20H16Cl2F3N5
MW: 454.3
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight454.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass453.0734854
Monoisotopic Mass453.0734854
Topological Polar Surface Area66.5 Ų
Heavy Atom Count30
Formal Charge0
Complexity537
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19164041-01Pexidartinib
GTR19172318-01Pexidartinib
GTR19224924-01NSC10010 hydrochloride
GTR19251079-01Tryptamine hydrochloride
GTR19250781Azetidine hydrochloride
GTR19157452-01Benzamil (hydrochloride)
GTR19157233-01Imeglimin hydrochloride
GTR19156886-01Propranolol hydrochloride
GTR19156853-01Dopexamine hydrochloride
GTR19156692-01Poziotinib hydrochloride

Alternative Products

CatalogName
A4687-10Pexidartinib hydrochloride
HY-16749A-01Pexidartinib (hydrochloride)
HY-16749AR-01Pexidartinib (hydrochloride) (Standard)
TRC-P293640-100MGPexidartinib Hydrochloride Salt
462308-01Pexidartinib

Popular Products